Penthrox Launch in the UK and Pricing Approval for Ireland
27 January 2016
ASX ANNOUNCEMENT
Penthrox Launch in the UK and Pricing Approval for Ireland
Medical Developments International Limited (ASX: MVP) is delighted to announce that its fast acting, category leading non-narcotic analgesic, Penthrox, was launched in the UK by Galen Limited on 25 January 2016.
In addition to the launch in the UK, MVP is delighted to announce Penthrox has received full pricing reimbursement approval from the Irish Medicine?s Board, which is another significant achievement.
For more information please refer to the following link ASX Announcement_Penthrox Launch in the UK and Pricing Approval for Ireland